TG Therapeutics Reports Q3 Revenue Growth and Raises Annual Guidance to $1 billion
TGTX TG Therapeutics Inc
$63.38 +5.94%
View chart & analysis → - 1TG Therapeutics recorded global revenue of approximately $260 million in Q3, growing about 61% year-over-year.
- 2TG Therapeutics reported Q3 operating profit of $85.9 million.
- 3TG Therapeutics raised its 2026 annual global revenue guidance to $1 billion.
So what's the key point?
TG Therapeutics earned much more revenue in Q3 than last year. The company has raised its target for the amount of money it expects to earn over the next year to $1 billion.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.